Lupin manufacturing site in Pune, India
November 10, 2022 10:54 AM ESTUpdated 04:01 PM
R&D
Pharma
FDA+
Manufacturing

Form 483 cites Lupin man­u­fac­tur­ing site in In­dia for con­t­a­m­i­na­tion and oth­er qual­i­ty con­trol ob­ser­va­tions

Tyler Patchen

News Reporter

The FDA has had its eye on the phar­ma­ceu­ti­cal man­u­fac­tur­er Lupin for a while, and now an­oth­er fa­cil­i­ty for the com­pa­ny has been in­spect­ed by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times